Pallas Health Sermorelin
Pallas Health lists Sermorelin injection at $199 a month after a first month at $89. Medication is included in that catalog price. Readers considering injectable sermorelin at Pallas Health who want a precise record of this treatment edge before comparing other sermorelin programs. The commercial terms were checked 22 August 2026; state access, clinician approval, dispensing details, and personal suitability remain separate questions.

The short answer for this provider-treatment pair: Pallas Health Sermorelin
Verify the Pallas Health sermorelin injection listing as its own decision, focusing on the injectable format and catalog terms instead of borrowing assumptions from the provider's NAD or GLP-1 offers.
Readers considering injectable sermorelin at Pallas Health who want a precise record of this treatment edge before comparing other sermorelin programs. A fair reading keeps Pallas Health's Sermorelin listing separate from adjacent products that may use a related medication or sit in the same provider catalog.
Do not blur this product with adjacent options: Sermorelin injection
Sermorelin injection is cataloged as a compounded product in Subcutaneous injection format. FDA states that compounded drugs are not FDA-approved and do not receive the same premarket review as approved drug products. Ask for the exact formulation and dispensing pharmacy before purchase. That status is central to this Pallas Health guide because a related medication name does not make branded, compounded, oral, nasal, and injectable products interchangeable.
Subcutaneous injection is the exact format attached to Pallas Health's offer, while the canonical owner describes this comparison unit as Compounded Sermorelin injection. Route matters for product identification, fulfillment, source selection, and a fair price comparison. This draft does not supply dose instructions, route conversions, or a claim that another formulation would have the same evidence, safety profile, convenience, or outcome.
The catalog-backed cost view: Pallas Health
Pallas Health's canonical offer lists Sermorelin injection at $199 a month after a first month at $89. The number is computed from the same registry fields used by the treatment comparison, not copied into this draft as a fixed editorial amount. That connection matters because a future catalog correction can update the displayed commercial fact without leaving this guide on a stale, contradictory figure.
The canonical offer marks medication as included in the displayed price. It does not verify that labs, every consultation, supplies, expedited shipping, or future dose changes are included unless the source says so. Those items remain checkout questions. For Pallas Health Sermorelin, read inclusion as one field in the offer record, not as proof that every service surrounding the prescription is free. The dated source establishes the advertised basis; it does not independently audit the final checkout, dispensing event, or quality of care.
Billing terms to settle before payment: Pallas Health Sermorelin
The catalog has both a continuing option at $199 a month after a first month at $89 and a prepaid option at $199 a month, paying $597 for 3 months up front. Those are different commitments. Compare the total charged today, the renewal path, and the cancellation deadline rather than treating the lowest monthly equivalent as month to month. This is why Telehealth Ledger keeps introductory, recurring, upfront, effective-monthly, and commitment fields separate for Pallas Health's Sermorelin offer. A monthly equivalent can be useful, but only when the required payment and term remain visible beside it.
The Pallas Health source for this edge was checked on 22 August 2026. Before paying for Sermorelin, compare the amount charged today with the amount charged later, the number of months purchased, the renewal date, the cancellation window, and the refund boundary after clinical or pharmacy processing. A current catalog price cannot safely answer those policy questions unless the cited provider evidence does.
Coverage, eligibility, and fulfillment: Sermorelin
The canonical provider record marks this prescribed-peptides program as available in all states as of its review date. Licensing, clinical eligibility, and fulfillment still need confirmation during intake. The Sermorelin access check belongs near the price because a low published figure has little decision value when Pallas Health cannot serve the reader's state or the selected product cannot be fulfilled there.
For Pallas Health Sermorelin, the consumer brand, administrative platform, clinical group, and dispensing pharmacy can be different entities. A provider page may describe a national service while licensure, product rules, and pharmacy coverage narrow actual fulfillment. Ask which clinician entity would review the intake and which licensed pharmacy would dispense this exact product in the reader's state before treating access as settled.
What the provider dossier adds: Pallas Health
Brentmoor, Inc. is recorded in the Pallas Health dossier as administrator. Administrative operator named by Pallas Health. These entities can perform different jobs, so the consumer-facing brand should not automatically be described as the clinician or dispensing pharmacy for Sermorelin.
Cancellation: Cancellation takes effect at the end of the current period through the published process. The dossier also preserves this boundary for Pallas Health's Sermorelin decision: Several jurisdictions require a synchronous video visit even though service is offered nationwide. Carry that dated limitation into checkout instead of assuming a catalog price settles operations, fulfillment, or eligibility.
Use the broader owner for ranking: Sermorelin
The linked Sermorelin owner is the right place to rank Pallas Health beside other cataloged offers. Use the same fields for every row: continuing price, introductory period, required prepayment, medication inclusion, product type, delivery format, verification date, and state evidence. If two offers use different routes or one price excludes medication, a simple lowest-number verdict would not be a like-for-like conclusion.
From this Pallas Health guide, the comparison link resolves to the canonical Sermorelin program owner, and the provider action uses the catalog's treatment-specific destination when one exists. Otherwise it uses the matching prescribed-peptides destination. That routing keeps the reader in the correct treatment lane and avoids sending a Sermorelin decision to an unrelated offer.
When this offer belongs on the shortlist: Pallas Health Sermorelin
Pallas Health's listing answers the basic commercial question for Sermorelin, but it cannot answer personal eligibility, medical fit, pharmacy assignment, or an individual outcome. Those limits belong in the decision, not in fine print after it.
Readers considering injectable sermorelin at Pallas Health who want a precise record of this treatment edge before comparing other sermorelin programs. Treat the provider link as a verification step: confirm the product name, price phase, medication inclusion, state rule, pharmacy, renewal date, and refund boundary before payment.
Pallas Health Sermorelin FAQ
- Which price belongs to this edge for Pallas Health Sermorelin?
- The canonical catalog records $199 a month after a first month at $89 for Sermorelin injection, checked 22 August 2026. The amount should be read with any introduction, prepayment, or commitment shown in the same offer record. It is a dated published commercial fact, not a promise that every checkout configuration, future renewal, or product change will cost the same amount.
- Is medication part of that number in the Pallas Health figure?
- The canonical Pallas Health offer marks medication as included for Sermorelin. That field does not automatically include labs, every consultation, supplies, faster shipping, dose-related price changes, or a future refill. Confirm those items and the complete charge in the selected checkout before treating the figure as all-inclusive.
- Can another route use these facts for Pallas Health Sermorelin?
- This record is limited to Sermorelin injection in Subcutaneous injection format. It does not transfer price, regulatory status, evidence, convenience, dosing, pharmacy, or fulfillment claims to another Sermorelin formulation or to a related product. Compare route and product identity before comparing the price because similar medication names can still describe materially different offers.
- Does an empty state list prove coverage for Pallas Health Sermorelin?
- The current provider record marks this vertical as all-states, but individual eligibility and fulfillment still require confirmation. The state record is only one access field. Pallas Health must also confirm clinician licensure, product eligibility, and pharmacy fulfillment for the specific Sermorelin prescription. Completing an intake does not guarantee approval, dispensing, or a particular outcome.
- Which page ranks alternatives for Pallas Health Sermorelin?
- Use the canonical Sermorelin program comparison. It reads current provider and price data from the registry and preserves the sermorelin-injection treatment route. Compare Pallas Health only with offers that disclose the same price components, medication inclusion, commitment, and format; otherwise explain why the rows are not directly equivalent.
Sources and method
Telehealth Ledger checked provider pages, plan terms, and independent context on 22 August 2026. This page compares published commercial terms. It is not a rating, medical advice, or a guarantee that a clinician will prescribe treatment.
- Pallas Health Sermorelin price source
- Pallas Health official website
- Pallas Health clinical network
- Pallas Health GLP-1 pricing
- Pallas Health NAD+ and sermorelin catalog
- Pallas Health brand-name GLP-1 pages
- Pallas Health terms
- FDA historical Geref withdrawal determination
- Sermorelin review in childhood growth hormone deficiency
- FDA questions and answers about drug compounding
- FDA overview of compounded-drug risks
